podiatryarena.com /18 hours ago

Melanoma of the foot

Management of primary cutaneous melanoma of the hands and feet: a clinicoprognostic study. Rex J, Paradelo C, Mangas C, Hilari JM, Fernández-Figueras MT, Ferrándiz C. Dermatol...

Read source
drugs.com /3 weeks ago

Cancer Vaccine Could Boost Melanoma Survival, Trial Finds

WEDNESDAY, Oct. 28, 2026 — A personalized cancer vaccine can significantly improve survival odds for patients with advanced melanoma, a new clinical trial has found.Adding the vac...

Read source
newatlas.com /3 weeks ago

Landmark melanoma vaccine cuts deaths in landmark trial

The results of a landmark cancer vaccine trial demonstrate the power of treatments tailored to the person receiving them, hinting at a future where cancer treatments are personaliz...

Read source
bioengineer.org /1 month ago

When the Sentinel Node Vanishes: Hidden Warning Sign in Head and Neck Melanoma

A seventeen-year study of 400 patients finds that failure to visualise the sentinel lymph node on preoperative imaging in head and neck melanoma affects nearly one in eleven patien...

Read source
drugs.com /3 weeks ago

AI Tool Helps Doctors Spot Skin Cancer

TUESDAY, Oct. 27, 2026 — Is that brown spot a sign of aging, or is it skin cancer?A new AI tool promises to help doctors suss out skin cancers, researchers reported Oct. 22 in the...

Read source
wired.com /4 weeks ago

New mRNA Vaccine Reduces Risk of Melanoma Recurrence by Over 40 Percent

The vaccine is personalized to a patient’s tumor, and results from the Phase 3 trial are yet another example of the promise of mRNA vaccines in treating cancer.

Read source
bioengineer.org /4 days ago

Local IL-12 and Flt3L mRNA Nanoparticles Control Checkpoint-Resistant Melanoma in Mice

Intratumoral co-administration of IL-12 and Flt3L mRNA lipid nanoparticles controlled anti-PD-1-refractory melanoma in mouse models by coordinating dendritic, natural killer, and T...

Read source
prweb.com /1 month ago

Robin Roberts Headlines the Melanoma Research Foundation's 25th Annual New York Gala

The Melanoma Research Foundation (MRF) will host its 25th Annual New York Gala on Thursday, October 15, at Guastavino's, marking a milestone celebration of the Gala's 25-year histo...

Read source
medicalxpress.com /1 month ago

Protecting young skin: A new approach to melanoma prevention for children

Children of parents who have melanoma, a serious type of skin cancer that starts in the cells that make pigment, have twice the lifetime risk of developing the disease themselves....

Read source
nytimes.com /4 weeks ago

Melanoma Vaccine Ushers in New Hope for Cancer Patients

Beyond melanoma, scientists are studying cancer vaccines for glioblastoma, pancreatic cancer and more.

Read source
fastcompany.com /4 weeks ago

A personalized cancer vaccine could be available as soon as 2027. Here’s what we know

A breakthrough treatment for the deadliest form of skin cancer can cut a patient’s risk of recurrence or death nearly in half.  The new scientific revelation is powered by an mR...

Read source
wlky.com /4 weeks ago

An mRNA cancer vaccine helps reduce the chances of melanoma patients' tumors returning

A first-of-its-kind cancer vaccine is helping significantly reduce the chances that melanoma patients' tumors return.

Read source
npr.org /3 weeks ago

Merck's melanoma vaccine trial shows reduced recurrence or death from skin cancer

Merck presented its mRNA melanoma vaccine trial data at a European cancer conference this weekend. Results are promising: The vaccine reduces recurrence and death alongside an immu...

Read source
stuff.co.nz /4 weeks ago

It’s being called a landmark moment in cancer treatment and it’s got scientists very excited

The international phase 3 trial involved 1137 people whose high-risk melanoma had been surgically removed.

Read source
khon2.com /4 weeks ago

A novel mRNA cancer vaccine helps reduce the chances of melanoma patients' tumors returning

A first-of-its-kind cancer vaccine is significantly reducing the chances that melanoma patients’ tumors come back.

Read source
aacr.org /3 weeks ago

From Promise to Proof: Personalized Melanoma mRNA Vaccine Delivers Phase III Success

Results from a phase III trial showed that a cancer vaccine can improve outcomes for certain patients with melanoma, highlighting the potential of personalized vaccines to reshape...

Read source
bioengineer.org /1 month ago

Rare Spinal Spread of Canine Mast Cell Tumours Revealed in Three Dogs

Mast cell tumours are the most familiar villain in canine dermatology, the single most common malignant skin cancer in dogs, accounting for an estimated 11 to 18 percent of all cut...

Read source
wsvn.com /4 weeks ago

Experimental mRNA vaccine cuts risk that melanoma returns by 42%

(CNN) — When the news arrived in August that what could be the first personalized mRNA cancer vaccine had succeeded in a late-stage clinical trial...

Read source
bioengineer.org /4 days ago

RNA Modification Regulates Melanoma Progression and Immune Response in Preclinical Studies

A comprehensive scientific review synthesizes preclinical evidence revealing how m6A RNA modification governs melanoma progression, immune escape, and response to checkpoint immuno...

Read source
inc.com /3 weeks ago

This Breakthrough Cancer Treatment Can Cut Risk by 42 Percent

A groundbreaking phase 3 clinical trial reveals that a personalized mRNA vaccine from Merck and Moderna significantly cuts the risk of melanoma returning.

Read source
nytimes.com /4 weeks ago

Cancer Vaccine Cuts the Risk of Melanoma Recurrence, Merck and Moderna Report

Merck and Moderna released detailed results on an experimental vaccine to treat the skin cancer.

Read source
nbcwashington.com /4 weeks ago

Experimental mRNA cancer vaccine cuts risk of melanoma returning by 42%: ‘A new frontier'

A first-of-its-kind cancer vaccine is significantly reducing the chances that melanoma patients’ tumors come back, according to results of a major study released Thursday by drugma...

Read source
elle.com /1 month ago

What to Know About the New Cancer Vaccine

The personalized shots show significant promise for certain melanoma subtypes.

Read source
wkbn.com /4 weeks ago

A novel mRNA cancer vaccine helps reduce the chances of melanoma patients' tumors returning

A first-of-its-kind cancer vaccine is significantly reducing the chances that melanoma patients’ tumors come back.

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.